Preferred Label : Jaypirca;
Origin ID : M000766008;
Related record
https://www.ema.europa.eu/en/medicines/human/EPAR/jaypirca
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
pirtobrutinib
pirtobrutinib
pirtobrutinib
orphan drug production
Jaypirca
drug approval
europe
antineoplastic agents
antineoplastic agents
adult
lymphoma, mantle-cell
BTK Inhibitor
Agammaglobulinaemia Tyrosine Kinase
Tyrosine Kinase Inhibitors
Tyrosine Kinase Inhibitors
Refractory Mantle Cell Lymphoma
Recurrent Mantle Cell Lymphoma
administration, oral
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
aged
drug evaluation, preclinical
---
